IL33 and pulmonary fibrosis: IL-33 has emerged as a critical regulator of several chronic inflammatory diseases, autoimmune diseases and fibrotic disorders including asthma, rheumatoid arthritis, ulcerative colitis, lung fibrosis and cardiovascular disease18,30,32–34.